USFDA inspection at Cipla Ltd's manufacturing facility in Patalganga, Maharashtra, India

The United States Food and Drug Administration (USFDA) vide communication dated Tuesday, 25th June 2024 (12:37 AM IST) has classified the routine current Good Manufacturing Practices (cGMP) inspection at Cipla Ltd's Patalganga manufacturing facility as Voluntary Action Indicated ("VAI").

Shares of Cipla Limited was last trading in BSE at Rs. 1499.40 as compared to the previous close of Rs. 1503.30. The total number of shares traded during the day was 72089 in over 4317 trades.

The stock hit an intraday high of Rs. 1519.20 and intraday low of 1495.65. The net turnover during the day was Rs. 108206287.00.

Source : Equity Bulls

Keywords

Cipla INE059A01026 USFDA cGMPInsepction PatalgangaFacility VAIstatus